Funding round led by Aescuvest alongside Omega Healthcare
Investors
JERUSALEM, April 25,
2023 /PRNewswire/ -- Neteera Technologies Ltd.,
an Israeli-based startup disrupting the patient monitoring market,
today announced the successful closing of a ~$13M Series B funding round. The round was led
by Aescuvest, a prominent healthcare investment firm combined with
existing and new investors, including Omega Healthcare Investors -
a leading US-based Healthcare REIT (NYSE: OHI) with a particular
focus on skilled nursing facility and assisted living facility
operators across the United States
and the United Kingdom, Nanz
Family Office, Ankor Holding and Esas Private Equity. In addition,
Neteera and Omega entered into a strategic partnership to offer
Neteera's technology to Omega's healthcare operating partners.
With this latest funding round, Neteera will accelerate sales,
production and deployment of its contactless patient monitoring
solution and further feature development for its proprietary
medical sensing platform. The technology is designed to enable
continuous monitoring of patients' bio markers without the need for
contact or patient involvement, streamlining patient monitoring,
improving outcomes, and reducing the burden on clinical staff.
"Aescuvest is committed to funding healthcare developments that
have a positive impact on society, and we believe that Neteera's
innovative technology has the potential to revolutionize the way we
monitor and care for patients," said Sebastian Gührs, Partner &
Head of Investment at Aescuvest.
Omega Healthcare Investors joined the investment round as well
and cemented a strategic partnership with Neteera. As part of the
relationship, Neteera will become Omega's strategic partner for
contactless patient monitoring and will offer its remote patient
monitoring platform to Omega's network of long-term care and
skilled nursing facilities across the US.
"We are excited to partner with Neteera," said Matthew Gourmand,
Senior Vice President, Corporate Strategy of Omega Healthcare
Investors. "We deployed their technology across a test group of
facilities and received positive feedback from the operators,
highlighting a reduction in hospitalizations and early recognition
of changes in resident clinical needs. We believe this technology
has the capacity to help caregivers, as they seek to provide high
levels of care and comfort for their residents."
Founded in 2015, Neteera quickly gained recognition for its
unique FDA-cleared contactless remote patient monitoring platform.
The platform, capable of continuous and seamless monitoring of
patients' bio markers in real-time, is improving patient care and
operator efficiencies all over the globe. Together with the FDA
clearance and the latest funding round, the company is poised to
further disrupt the healthcare industry and bring its technology to
more patients in need.
"We are thrilled to partner with Aescuvest and Omega as we
continue to develop and scale our game changing solution," said
Neteera CEO, Isaac Litman. "With
this funding and with Omega's strategic partnership, we will be
able to expand our reach and accelerate our mission to improve
patient outcomes while reducing the burden on clinical staff."
About Aescuvest:
Aescuvest is a healthcare investment company that focuses on
funding digital healthcare ventures to make a significant impact.
As the operator of a dedicated investment platform, the company
offers exclusive access to promising healthcare ventures and
facilitates direct investments through SPV structures. By providing
entrepreneurial investments in a thriving market, Aescuvest enables
investors to participate in lucrative healthcare investment
opportunities.
About Omega Healthcare Investors:
Omega is a REIT that invests in the long-term healthcare
industry, primarily in skilled nursing and assisted living
facilities. Its portfolio of assets is operated by a diverse group
of healthcare companies, predominantly in a triple-net lease
structure. The assets span all regions within the U.S., as well as
in the U.K.
About Neteera:
Neteera's FDA-cleared continuous, contactless, passive vital
signs and bio-data monitoring solution provides better patient
monitoring both for the crisis ridden healthcare system and home
health. Our sensing platform eliminates the need for device
manipulation, removal of clothing, and caregiver presence.
Neteera's technology is a based on a safe, maintenance-free,
sub-THZ micro-radar on chip sensor solution that protects privacy
as it is not based on a camera. We improve care and ultimately
reduce healthcare costs by enabling optimal comfort for
patients.
Contact:
Sebastian Gührs
Head of Investment
Aescuvest
+491744333221
sebastian.guehrs@aescuvest.eu
Logo -
https://mma.prnewswire.com/media/2058115/Aescuvest_Logo.jpg
Logo -
https://mma.prnewswire.com/media/2058116/Omega_Healthcare_Investors_Logo.jpg
Logo -
https://mma.prnewswire.com/media/2058117/Neteera_Logo.jpg
View original content to download
multimedia:https://www.prnewswire.com/news-releases/neteera-secures-13m-series-b-funding-for-contactless-patient-monitoring-301802870.html
SOURCE Aescuvest